Phylagen Receives Rigorous AOAC Validation for COVID-19 Indoor Testâ„¢

▴ Phylagen Receives Rigorous AOAC Validation for COVID-19 Indoor Testâ„¢
Phylagen recently awarded a Certificate of Validation from AOAC INTERNATIONAL for its COVID-19 Indoor Testâ„¢ that detects SARS-CoV-2 in any built environment.

Phylagen, the San Francisco-based biotech company focused on decoding the environmental microbiome for indoor safety was recently awarded a Certificate of Validation from AOAC INTERNATIONAL for its COVID-19 Indoor Test™ that detects SARS-CoV-2 in any built environment. Phylagen's test is one of the first to pass the rigorous independent evaluation required by the AOAC Research Institute's Performance Tested Methods™ Program and is currently the only certified SARS-CoV-2 indoor test kit solution available for anyone to purchase directly online.

Phylagen partnered with AOAC INTERNATIONAL at the beginning of the pandemic to be one of the first companies to undergo the rigorous test. During this initial validation process, the Phylagen COVID-19 Indoor Test™ and two other kits were evaluated for detection of the virus. To date, there has been no third-party certification available for indoor environmental testing.

"The rigor the AOAC brings makes it significant for Phylagen to be among the first cohort to receive AOAC's new Certificate of Validation for environmental testing of SARS-CoV-2," said Dr. Brad Taft, Ph.D., Chief Scientific Officer, Phylagen. "The emergence of the AOAC certification reinforces that indoor environmental testing for early detection of COVID-19 is becoming an evermore ubiquitous and essential tool for keeping populations in shared spaces safe."

The COVID-19 Indoor Test™ by Phylagen is a SARS-CoV-2 quantitative detection method that extracts the SARS-CoV-2 RNA from environmental swabs and detects it utilizing RT- PCR technology. Environmental surface swabs are collected by the customer and shipped back to Phylagen, Inc. for sample processing. Sample data are analyzed, and results are reported through a tracking portal.

Since the start of the pandemic, a wide range of businesses has turned to Phylagen to protect their workers by implementing regular indoor environmental testing. Manufacturing facilities shared workspaces, schools, and assisted living homes are just some of the businesses that have partnered with Phylagen to identify the presence of COVID-19.  The COVID-19 Indoor Test™ can be purchased online starting at $189 for five swabs. Custom solutions are also available for purchase. Once Phylagen receives the completed test swabs, results are delivered within 24 hours.  

About Phylagen

Phylagen is a San Francisco based biotech company committed to unlocking the global microbiome of built spaces. Phylagen's internationally recognized team of scientists turn dust into genomic data, providing crucial microbiome insights that impact indoor building health, supply chain traceability, and more.

Tags : #Phylagen #SANFRANCISCO #biotechcompany #AOACINTERNATIONAL #CertificateofValidation #Award #COVID-19IndoorTest #SARS-CoV-2 #ResearchInstitutesPerformanceTestedMethods #Covid-19Test #Covid-19Patients #DailyCovidUpdates

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024
Kamineni Doctors Successfully Remove Bone Stuck Near Heart in Elderly PatientMay 14, 2024
On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology NursesMay 14, 2024
Shiprocket announces Shiprocket Growth Academy to upskill 100,000 Indian MSMEs through eCommerce learningMay 14, 2024